UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Biosimilars are better than originals’
by Park Gi-taek
2018-05-16 15:56
Will Deloitte’s prediction of clinical success work?
by Park Gi-taek
2018-05-03 13:12
Gastric cancer drug Cyramza to get insurance benefit
by Park Gi-taek
2018-04-25 11:11
Obesity guidelines set anew in 3 stages
by Park Gi-taek
2018-04-11 16:45
Medical equipment makers feel threatened by ‘Mooncare’
by Park Gi-taek
2018-03-27 16:39
라인
Why is biopharmaceutical outlook rosy, despite bubble concern?
by Park Gi-taek
2018-03-21 16:04
Will restructuring wind sweep the domestic pharmaceutical industry?
by Park Gi-taek
2018-03-16 18:29
Korea Otsuka not listening to sexual abuse victim
by Park Gi-taek
2018-01-19 15:58
‘VIVIX, innovative flat panel detector for radiography’
by Park Gi-taek
2018-01-03 06:30
‘More accurate diagnosis of preeclampsia possible’
by Park Gi-taek
2017-12-14 11:38
라인
Secrets of ezCaretech’s overseas expansion success
by Park Gi-taek
2017-12-08 15:09
Korea’s healthcare exports to reach $11.7 billion this year
by Park Gi-taek
2017-12-07 14:10
‘Treatment of atopic dermatitis enhances kids’ mental health’
by Park Gi-taek
2017-11-30 16:22
Novartis Korea mired in sexual harassment scandal
by Park Gi-taek
2017-11-29 14:58
‘Oral anticoagulants will be widely used for specific atrial fibrillation patients’
by Park Gi-taek
2017-10-19 06:30
라인
Former MFDS officials enjoy parachute positions: lawmaker
by Park Gi-taek
2017-10-17 16:05
‘AstraZeneca’s lung cancer drug may not get insurance coverage’
by Park Gi-taek
2017-10-13 14:02
Experts grade on Vemlidy, new treatment for hepatitis B
by Park Gi-taek
2017-10-10 10:53
Social, economic cost of COPD reaches ₩1.4 trillion a year
by Park Gi-taek
2017-09-27 14:09
Oncolytic virotherapy association launched in Korea
by Park Gi-taek
2017-09-22 16:13
-
1
2
3
4
5
6
7
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top